Sendum

Sendum offers Advanced Therapy Visibility Solutions for Life Science companies. We help our customers maintain product integrity and visibility across their value chain, reducing their losses by up to 70%. Sendum’s advantage is our real-time visibility enabling a proactive response. We are the industry leader with over 60% of all active CGT clinical trials and commercially available CGT products.

Founded in 2001 and headquartered in Canada, Sendum operates at the intersection of Drones, Manufacturing, and Transportation industries, offering innovative solutions in the field of advanced therapy visibility.

Although specific details about its last investment and participating investors are currently unavailable, Sendum's track record, industry standing, and pioneering solutions make it a compelling prospect for potential investment opportunities.